ONMDHealthcare · Health Information Services

ONMD Stock Forecast: OneMedNet Corp. Price Predictions for 2026-2027

Last close, 12 Oct 2026

$3.93

−8.60% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 12 of 100 as at 12 Oct 2026 — in the weakest quartile.

Market cap

$25.0M

Ticker Nerd rank

12 / 100

Median analyst target

—

Analysts covering

—

Revenue$292K+88.4% y/y

Operating income−$2.3M

Net income−$2.2M

Free cash flow−$1.9M

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−23.1%

−39.8%

YTD

−64.3%

−87.5%

From 52W high

−86.9%

From 52W low

0.0%

$30

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

ONMD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores OneMedNet Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Oct 2026

12 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Accruals

Momentum

Growth

Revisions

Volatility

Value

Issuance

Quality

Size (87): Smaller than most of the companies we track.

Quality (2): Profits are thin or unreliable for the size of the business, or they are not turning into cash.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ONMD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ONMD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ONMD appears on the weeks it earns a place.

Performance

ONMD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 12 Oct 2026, OneMedNet Corp. returned −87.5% against +20.4% for the S&P 500, dividends included.

ONMD vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ONMD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

OneMedNet Corp. (ONMD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 45.0×
Price / sales: 16.0×
Price / book: −65.5×
EV / EBITDA: −2.9×

Growth & margins

Revenue growth (YoY): 88.4%
Earnings growth (YoY): 88.4%
Gross margin: −193.5%
Operating margin: −774.3%
Net margin: −37.0%

Returns & dividend

Return on equity: 94.5%
Return on assets: −342.1%
Dividend yield: 0.0%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

OneMedNet Corp. (ONMD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

OneMedNet Corp. has a market value of $25.0M and an enterprise value of $28.9M.
Revenue in the twelve months to 30 June 2026: $1.5M. The latest quarter grew 88.4% year on year.
Net income over the same four quarters: −$8.5M, a −584.2% net margin.
Free cash flow in the twelve months to 30 June 2026: −$6.9M.
Shares outstanding: 57.7M.
Trailing P/E: 45.0×.
Forward dividend yield: 0.00%, paying out 0% of earnings.
OneMedNet Corp. employs 22 people — $66K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 12 Oct 2026

Data provided by Twelve Data

Peers

ONMD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services

Company	Market cap	TKN rank
ONMDOneMedNet Corp.	$25.0M	12
BEATHeartBeam, Inc.	$23.9M	19
BFRGBullFrog AI Holdings, Inc.	$10.8M	53
DRIODarioHealth Corp.	$53.1M	55
MGRXMangoceuticals, Inc.	$8.3M	40
CCLDCareCloud, Inc.	$82.4M	70
ACONAclarion, Inc.	$6.5M	29

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own OneMedNet Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ONMD news & analysis

OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company's Real World Data Footprint into Korea and the Asia Pacific Region

GlobeNewsWire · 7 Oct 2026positive

OneMedNet signed its 11th channel partner agreement, appointing Korean healthcare data company Mediplexus as distributor of its U.S.-sourced Real World Data in Korea. The company said the agreement expands its commercial reach into the broader Asia Pacific region.

Why it matters — The partnership adds a distribution channel in Korea and extends OneMedNet's stated Real World Data footprint into Asia Pacific.

OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution

GlobeNewsWire · 30 Sept 2026positive

OneMedNet announced a seven-figure, multiyear agreement to provide de-identified, multimodal, longitudinal clinical Real World Data to a commercially scaled AI-enabled precision medicine company that will integrate it into a partner-sold derivative data solution.

Why it matters — This multiyear, seven-figure deal signals a meaningful new commercial revenue stream for OneMedNet's Real World Data offerings in the precision medicine space.

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

GlobeNewsWire · 25 Sept 2026neutral

OneMedNet Corporation announced it will implement a 1-for-10 reverse stock split of its issued and outstanding shares of common stock, effective at 12:01 a.m. The split applies to the company's common stock traded under Nasdaq: ONMD.

Why it matters — A OneMedNet watcher would care because a reverse stock split changes the share count and price structure of the company's common stock, which can affect shareholders and market perception.

Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model Development

Business Wire · 22 Sept 2026positive

Atropos Health announced an expansion of its federated Atropos Evidence Network, including deeper collaborations with Norstella and Arcadia and new data partnership agreements with OneMedNet Corporation (Nasdaq: ONMD), extending the scope of its healthcare data ecosystem across clinical decision support and model training.

Why it matters — For OneMedNet watchers, the new agreement positions ONMD as an official data partner within Atropos Health's growing federated evidence network, expanding its role in real-world health data and AI applications.

OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health

GlobeNewsWire · 22 Sept 2026positive

OneMedNet announced a strategic partnership with Atropos Health under a multi-year resale agreement, aimed at expanding its commercial reach for its regulatory decision-grade, AI-driven Real-World Data (RWD).

Why it matters — This multi-year partnership with Atropos Health broadens OneMedNet's distribution channels and commercial presence for its Real-World Data offerings.

FAQ

Frequently asked questions about ONMD stock

How does Ticker Nerd's model rank ONMD?

As at 12 Oct 2026, OneMedNet Corp. ranks 12 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (87 of 100).

What is the ONMD stock forecast for 2030?

No analyst covering OneMedNet Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ONMD are extrapolating price history, which says nothing about the business.

How has ONMD stock performed over the past year?

OneMedNet Corp. returned -87.5% over the 12 months to 12 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does OneMedNet Corp. do?

OneMedNet Corp. Class A Common Stock represents the publicly traded equity of OneMedNet Corp., a healthcare technology company focused on clinical imaging and real-world data services.

What is the latest news on ONMD?

The most recent item we track (GlobeNewsWire, 7 Oct 2026): "OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company's Real World Data Footprint into Korea and the Asia Pacific Region". OneMedNet signed its 11th channel partner agreement, appointing Korean healthcare data company Mediplexus as distributor of its U.S.-sourced Real World Data in Korea. The company said the agreement expands its commercial reach into the broader Asia Pacific region.

Company

About OneMedNet Corp.

OneMedNet Corp. Class A Common Stock represents the publicly traded equity of OneMedNet Corp., a healthcare technology company focused on clinical imaging and real-world data services. OneMedNet provides digital medical image management, exchange, and sharing solutions used across healthcare and life sciences workflows. Its core offerings include iRWD, a platform designed to securely de-identify, curate, search, and share imaging data for medical institutions, research organizations, and industry partners. The company also supports the movement of clinical images and related patient data between providers, hospitals, and research networks. OneMedNet serves customers in the Americas, Europe, and the Middle East, positioning itself within the health information services segment of the market. The stock is associated with a company whose products are centered on imaging data access, regulatory-grade data handling, and clinical research support.

CEO Mr. Aaron Green · 22 employees · United States · https://www.onemednet.com